These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 30196791)

  • 1. Incidence of atrial fibrillation among patients with an embolic stroke of undetermined source: Insights from insertable cardiac monitors.
    Verma N; Ziegler PD; Liu S; Passman RS
    Int J Stroke; 2019 Feb; 14(2):146-153. PubMed ID: 30196791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of atrial fibrillation in patients with embolic stroke of undetermined source by prolonged monitoring with implantable loop recorders.
    Israel C; Kitsiou A; Kalyani M; Deelawar S; Ejangue LE; Rogalewski A; Hagemeister C; Minnerup J; Schäbitz WR
    Thromb Haemost; 2017 Oct; 117(10):1962-1969. PubMed ID: 28862284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between Bilateral Infarcts Pattern and Detection of Occult Atrial Fibrillation in Embolic Stroke of Undetermined Source (ESUS) Patients with Insertable Cardiac Monitor (ICM).
    Yushan B; Tan BYQ; Ngiam NJ; Chan BPL; Luen TH; Sharma VK; Sia CH; Dalakoti M; Chong SS; Kojodjojo P; Yeo LLL
    J Stroke Cerebrovasc Dis; 2019 Sep; 28(9):2448-2452. PubMed ID: 31307898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of Atrial Fibrillation Development in Patients With Embolic Stroke of Undetermined Source: An Analysis of the RE-SPECT ESUS Trial.
    Bahit MC; Sacco RL; Easton JD; Meyerhoff J; Cronin L; Kleine E; Grauer C; Brueckmann M; Diener HC; Lopes RD; Brainin M; Lyrer P; Wachter R; Segura T; Granger CB;
    Circulation; 2021 Nov; 144(22):1738-1746. PubMed ID: 34649459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and predictors of atrial fibrillation in patients with embolic stroke of undetermined source: a real-life single-center retrospective study.
    Melis F; Guido M; Amellone C; Suppo M; Bonanno M; Bovio C; Pessia A; Savio K; Lucciola MT; Ebrille E; Guastamacchia G; Cassano D; Filippi P; Milano E; Giammaria M; Imperiale D
    Neurol Sci; 2021 Sep; 42(9):3707-3714. PubMed ID: 33443664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of an insertable cardiac monitor to detect atrial fibrillation in patients with cryptogenic stroke.
    Diamantopoulos A; Sawyer LM; Lip GY; Witte KK; Reynolds MR; Fauchier L; Thijs V; Brown B; Quiroz Angulo ME; Diener HC
    Int J Stroke; 2016 Apr; 11(3):302-12. PubMed ID: 26763916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apixaban for treatment of embolic stroke of undetermined source (ATTICUS randomized trial): Rationale and study design.
    Geisler T; Poli S; Meisner C; Schreieck J; Zuern CS; Nägele T; Brachmann J; Jung W; Gahn G; Schmid E; Bäezner H; Keller T; Petzold GC; Schrickel JW; Liman J; Wachter R; Schön F; Schabet M; Lindner A; Ludolph AC; Kimmig H; Jander S; Schlegel U; Gawaz M; Ziemann U
    Int J Stroke; 2017 Dec; 12(9):985-990. PubMed ID: 27881833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of Finding Embolic Sources for Patients with Embolic Stroke of Undetermined Source.
    Umemura T; Nishizawa S; Nakano Y; Saito T; Kitagawa T; Miyaoka R; Suzuki K; Yamamoto J
    J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):1810-1815. PubMed ID: 31097326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Embolic Stroke of Undetermined Source and Detection of Atrial Fibrillation on Follow-Up: How Much Causality Is There?
    Ntaios G; Papavasileiou V; Lip GY; Milionis H; Makaritsis K; Vemmou A; Koroboki E; Manios E; Spengos K; Michel P; Vemmos K
    J Stroke Cerebrovasc Dis; 2016 Dec; 25(12):2975-2980. PubMed ID: 27612625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uncovering Atrial Fibrillation Beyond Short-Term Monitoring in Cryptogenic Stroke Patients: Three-Year Results From the Cryptogenic Stroke and Underlying Atrial Fibrillation Trial.
    Brachmann J; Morillo CA; Sanna T; Di Lazzaro V; Diener HC; Bernstein RA; Rymer M; Ziegler PD; Liu S; Passman RS
    Circ Arrhythm Electrophysiol; 2016 Jan; 9(1):e003333. PubMed ID: 26763225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Covert atrial fibrillation and atrial high-rate episodes as a potential cause of embolic strokes of undetermined source: Their detection and possible management strategy.
    Tomita H; Sasaki S; Hagii J; Metoki N
    J Cardiol; 2018 Jul; 72(1):1-9. PubMed ID: 29609876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardioembolic Stroke.
    Kamel H; Healey JS
    Circ Res; 2017 Feb; 120(3):514-526. PubMed ID: 28154101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary Stroke Prevention Following Embolic Stroke of Unknown Source in the Absence of Documented Atrial Fibrillation: A Clinical Review.
    Kotadia ID; Sim I; Mukherjee R; O'Hare D; Chiribiri A; Birns J; Bhalla A; O'Neill M; Williams SE
    J Am Heart Assoc; 2021 Jul; 10(13):e021045. PubMed ID: 34212774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source.
    Diener HC; Sacco RL; Easton JD; Granger CB; Bernstein RA; Uchiyama S; Kreuzer J; Cronin L; Cotton D; Grauer C; Brueckmann M; Chernyatina M; Donnan G; Ferro JM; Grond M; Kallmünzer B; Krupinski J; Lee BC; Lemmens R; Masjuan J; Odinak M; Saver JL; Schellinger PD; Toni D; Toyoda K;
    N Engl J Med; 2019 May; 380(20):1906-1917. PubMed ID: 31091372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryptogenic Stroke and Embolic Stroke of Undetermined Source: Risk Factors and Approaches for Detection of Atrial Fibrillation.
    Rakhimova I; Semenova Y; Khaibullin T; Kuanysheva A; Kovalchuk V; Abdrakhmanov A
    Curr Cardiol Rev; 2022; 18(4):e211221199213. PubMed ID: 34939547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Covert Atrial Fibrillation in Cryptogenic Ischemic Stroke: Current Clinical Practice in Japan.
    Toyoda K; Okumura K; Hashimoto Y; Ikeda T; Komatsu T; Hirano T; Fukuda H; Matsumoto K; Yasaka M
    J Stroke Cerebrovasc Dis; 2016 Aug; 25(8):1829-37. PubMed ID: 27282299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of patients with embolic stroke of undetermined source and low risk of new incident atrial fibrillation: The AF-ESUS score.
    Ntaios G; Perlepe K; Lambrou D; Sirimarco G; Strambo D; Eskandari A; Karagkiozi E; Vemmou A; Korompoki E; Manios E; Makaritsis K; Vemmos K; Michel P
    Int J Stroke; 2021 Jan; 16(1):29-38. PubMed ID: 32423317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential Embolic Sources and Outcomes in Embolic Stroke of Undetermined Source in the NAVIGATE-ESUS Trial.
    Ntaios G; Pearce LA; Veltkamp R; Sharma M; Kasner SE; Korompoki E; Milionis H; Mundl H; Berkowitz SD; Connolly SJ; Hart RG;
    Stroke; 2020 Jun; 51(6):1797-1804. PubMed ID: 32295509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stroke Prevention in Atrial Fibrillation: Looking Forward.
    Katsanos AH; Kamel H; Healey JS; Hart RG
    Circulation; 2020 Dec; 142(24):2371-2388. PubMed ID: 33315494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic Treatment of Embolic Stroke of Undetermined Source: RE-SPECT ESUS Elderly and Renally Impaired Subgroups.
    Diener HC; Sacco RL; Easton JD; Granger CB; Bar M; Bernstein RA; Brainin M; Brueckmann M; Cronin L; Donnan G; Gdovinová Z; Grauer C; Kleine E; Kleinig TJ; Lyrer P; Martins S; Meyerhoff J; Milling T; Pfeilschifter W; Poli S; Reif M; Rose DZ; Šaňák D; Schäbitz WR
    Stroke; 2020 Jun; 51(6):1758-1765. PubMed ID: 32404035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.